or Try an Advanced Search...

    Technical Analysis for BCDA - BioCardia, Inc.

    Grade Last Price % Change Price Change
    F 1.99 -1.97% -0.04
    BCDA closed down 1.97 percent on Wednesday, November 20, 2024, on 42 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BCDA trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish -1.97%
    NR7 Range Contraction -1.97%
    Narrow Range Bar Range Contraction -1.97%
    Lower Bollinger Band Walk Weakness -1.97%
    Inside Day Range Contraction -1.97%
    Wide Bands Range Expansion -1.97%
    Oversold Stochastic Weakness -1.97%
    Older End-of-Day Signals for BCDA ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % about 21 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    Outside Day about 21 hours ago
    Fell Below Previous Day's Low about 21 hours ago
    Down 1% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BCDA Chart by TradingView
    Basic chart:

    Profile

    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Bone Stem Cell Cell Therapy Catheter Cardiovascular Disease Heart Failure Vascular Disease Regenerative Medicine Heart Disease Aging Associated Diseases Vascular Access Products Bone Marrow Ischemia Treatment Of Heart Failure

    Is BCDA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 16 BioCardia Third Quarter 2024 Earnings: US$0.61 loss per share (vs US$1.79 loss in 3Q 2023)
    Nov 14 BioCardia Inc (BCDA) Q3 2024 Earnings Call Highlights: Breakthroughs and Challenges in Cardiac ...
    Nov 14 BioCardia, Inc. (BCDA) Q3 2024 Earnings Call Transcript
    Nov 13 BioCardia GAAP EPS of -$0.61 beats by $0.58
    Nov 13 BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results
    Nov 13 Earnings Scheduled For November 13, 2024
    Nov 6 BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024
    Oct 28 BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
    Oct 9 BioCardia Inc (BCDA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
    Sep 18 BioCardia regains compliance with Nasdaq Capital Market
    See more BCDA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.9485
    52 Week Low 1.84
    Average Volume 112,456
    200-Day Moving Average 4.13
    50-Day Moving Average 2.55
    20-Day Moving Average 2.29
    10-Day Moving Average 2.16
    Average True Range 0.19
    RSI (14) 37.11
    ADX 12.79
    +DI 21.29
    -DI 25.76
    Chandelier Exit (Long, 3 ATRs) 2.19
    Chandelier Exit (Short, 3 ATRs) 2.41
    Upper Bollinger Bands 2.67
    Lower Bollinger Band 1.91
    Percent B (%b) 0.11
    BandWidth 33.30
    MACD Line -0.16
    MACD Signal Line -0.13
    MACD Histogram -0.0295
    Fundamentals Value
    Market Cap 47 Million
    Num Shares 23.6 Million
    EPS -0.62
    Price-to-Earnings (P/E) Ratio -3.21
    Price-to-Sales 17.62
    Price-to-Book 10.67
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.30
    Resistance 3 (R3) 2.33 2.26 2.25
    Resistance 2 (R2) 2.26 2.18 2.24 2.23
    Resistance 1 (R1) 2.12 2.13 2.08 2.09 2.22
    Pivot Point 2.05 2.05 2.03 2.03 2.05
    Support 1 (S1) 1.91 1.97 1.88 1.89 1.76
    Support 2 (S2) 1.84 1.92 1.82 1.75
    Support 3 (S3) 1.70 1.84 1.73
    Support 4 (S4) 1.68